Previous studies have shown that PD-L1 expression, tumor mutational burden (TMB), microsatellite instability (MSI), deficient DNA mismatch repair (dMMR), immune microenvironment (CD8 + T cell and immune factors), and neoantigen load can predict the response of various tumor types to ICIs [5–13]. This evidence concerns the gene CD8A and neoplasm.